Urological Research

, Volume 25, Issue 4, pp 223–230 | Cite as

Progress of fundamental research in Wilms' tumor

  • J. G. Wen
  • G. J. van Steenbrugge
  • R. M. Egeler
  • R. M. Nijman
Original Paper


The progress of fundamental research on the histopathological and molecular genetic properties, model systems, growth factor involvement, and tumor markers of clinical nephroblastoma (Wilms' tumor) are reviewed. Histologically, Wilms' tumor (WT) has been found to reveal a disorganized renal developmental process in which blastema and epithelia are randomly interspersed in varying amounts of stroma. Anaplasia is the only criterion for assigning a WT as having an “unfavorable histology.” Cytogenetic analysis identified WT genes at chromosome 11p13 (WTI), 11p15 region (WT2), and 16q (WT3). Permanent in vitro WT cell lines and in vivo WT models, such as human xenografts, have been established which provide indefinite sources of tumor material for fundamental, as well as therapy-directed, research. Abnormalities of growth factor (GF) expression in WT indicate that GF may play an important role in WT pathogenesis. A series of monoclonal antibodies was tested in WT by immunohistochemical techniques to identify specific diagnostic and prognostic markers. p53 expression in anaplastic WT is significantly higher than in differentiated WTs, indicating p53 may be a prognostic marker. Although significant progress has been made in the fundamental research, our basic knowledge of this malignancy is still limited. The availability of suitable experimental models, particularly the human xenograft system, offers the opportunity for further study of the cell biological and molecular aspects of WT and its clinical progression.

Key words

Wilms' tumor Histopathology Experimental model Tumor markers Growth factors 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Alpers CE, Hudkins KL, Ferguson M, Johnson RJ, Rutledge JC (1995) Platelet-derived growth factor A-chain expression in developing and mature human kidneys and in Wilms' tumor. Kidney Int 48:146Google Scholar
  2. 2.
    Aprikian AG, Sarkis AS, Fair WR, Zhang ZF, Fuks Z, Cordon-Cardo C (1994) Immunohistochemical determination of p53 protein nuclear accumulation in prostate adenocarcinomas. J Urol 151:1276Google Scholar
  3. 3.
    Baker ST, Fearan ER, Nigro JM (1989) Chromosome 17 deletions and p53 gene mutations in colorectal carcinoma. Science 244:217Google Scholar
  4. 4.
    Bardeesy N, Falkoff D, Petruzzi MJ, Nowak N, Zabel B, Adam M, Aguiar MC, Grundy P, Shows T, Pelletier J (1994) Anaplastic Wilms' tumor, a subtype displaying poor prognosis, harbours p53 gene mutations. Nat Genet 7:91Google Scholar
  5. 5.
    Bardeesy N, Beckwith B, Pelletier J (1995) Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations. Cancer Res 55:215Google Scholar
  6. 6.
    Beckwith JB (1983) Wilms' tumor and other renal tumors of childhood: A selective review from the National Wilms' Tumor Study Pathology Center. Human Pathol 14:482Google Scholar
  7. 7.
    Beckwith JB (1988) Pathological aspects of renal tumors in childhood. In: Broecker BH, Klein FA (eds) Pediatric tumors of the genitourinary tract. Alan R Liss, New York, p 25Google Scholar
  8. 8.
    Beckwith JB (1994) Renal tumors in the pediatric patient. In: Tisher CC, Brenner BM (eds) Renal pathology: With clinical and functional correlations. 2nd edn, J.B.Lippincott, Philadelphia, p 1513Google Scholar
  9. 9.
    Beckwith JB, Kiviat NB, Bonadio JF (1990) Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol 10:1Google Scholar
  10. 10.
    Beierle JW, Heimerl DM, Allerton SE, Bavetta LA (1971) Growth promotion by extracts from Wilms' tumor in vitro. Experientia 27:435Google Scholar
  11. 11.
    Bonadio JF, Storer B, Norkool P, Farewell VT, Beckwith JB, D'Angio GJ (1985) Anaplastic Wilms' tumor: clinical and pathologic studies. J Clin Oncol 3:513Google Scholar
  12. 12.
    Chang F, Syrjanen S, Kurmen K, Syrjanen K (1993) The p53 tumor suppressor gene as a common cellular target in human carcinogenesis. Am J Gastroenterol 88:174Google Scholar
  13. 13.
    Cheah PL, Loci LM, Chan LL (1996) Immunohistochemical expression of p53 proteins in Wilms' tumor: a possible association with the histological prognostic parameter of anaplasia. Histopathology 28:49Google Scholar
  14. 14.
    Clarke AR (1995) Murine models of neoplasia: functional analysis of the tumor suppressor genes Rb-1 and p53. Cancer Metastasis Rev 14:125Google Scholar
  15. 15.
    Clemmons DR (1992) IGF binding proteins:regulators of cellular actions. Growth Regul 2:80Google Scholar
  16. 16.
    D'Angio GJ, Evans AE, Breslow NE, Sharles K (1989) The treatment of Wilms' tumor: results of the Third National Wilms' Study. Cancer 64:349Google Scholar
  17. 17.
    Delahunt B, Farrant GJ, Bethwaite PB, Nacey JN, Lewis ME (1994) Assessment of proliferative activity in Wilms' tumor. Anal Cell Pathol 7:127Google Scholar
  18. 18.
    Donovan MJ, Hempstead B, Huber LJ, Kaplan D, Tsoulfas P, Chao M, Parada L, Schofield D (1994) Identification of the neurotrophin receptors p75 and trk in a series of Wilms' tumors. Am J Pathol 145:792Google Scholar
  19. 19.
    Dowdy SF, Weissman BE, Stanbridge EJ (1991) Correlation of the inability to sustain growth in defined serum-free medium with the suppression of tumorigenicity in Wilms' nephroblastoma. J Cell Physiol 147:248Google Scholar
  20. 20.
    Drop SLS, Schuller AGP, Lindenbergh-Kortleve DJ, Groffen C, Brinkman A, Zwarthoff EC (1992) Structural aspects of the IGFBP family. Growth Reg 2:60Google Scholar
  21. 21.
    Droz D, Rousseau-Merck MF, Jaubert F, Diebold N, Nezelof C, Adafer E, Mouly H (1990) Cell differentiation in Wilms' tumor (nephroblastoma): an immunohistochemical study. Hum Pathol 21:536Google Scholar
  22. 22.
    Durbeej M, Soderstrom S, Ebendal T, Birchmeier, Ekblom P (1993) Differential expression of neurotrophin receptors during renal development. Development 119:977Google Scholar
  23. 23.
    Fearon ER, Vogelstein B, Feinberg AP (1984) Somatic deletion and duplication of genes on chromosome 11 in Wilms' tumours. Nature 309:176Google Scholar
  24. 24.
    Fraizer GE, Bowen-Pope DF, Vogel AM (1987) Production of platelet-derived growth factor by cultured Wilms' tumor cells and fetal kidney cells. J Cell Physiol 133:169Google Scholar
  25. 25.
    Gansler T, Allen KD, Inabnett T, Scptt A, Buse MG, Sens DA, Gervin AJ (1988) Detection of type-I insulin-like growth factor (IGF) receptor in Wilms' tumors. Am J Patholol 130:431Google Scholar
  26. 26.
    Gansler T, Furlanetto R, Gramoing TS, Robinson KA, Blocker N, Buse MG, Sens DA, Garvin AJ (1989) Antibody to type I insulin-like growth factor receptor inhibits growth of Wilms' tumor in culture and in athymic nude mice. Am J Pathol 135:961Google Scholar
  27. 27.
    Garvin AJ, Surrette F, Hintz DS, Rudisill MT, Sens MA, Sens DA (1985) The in vitro growth and characterization of the skeletal component of Wilms' tumor. Am J Pathol 121:298Google Scholar
  28. 28.
    Garvin AJ, Sollivan JL, Bennett DD, Stanley WS, Inanmett T, Sens DA (1987) The in vitro growth, heterotransplantation, and immunohistochemical characterization of the blastema component of Wilms' tumor. Am J Pathol 129:353Google Scholar
  29. 29.
    Garvin AJ, Congleton L, Inabnett T, Gansler T, Sens DA (1988) Growth characteristics of human Wilms' tumor in nude mice. Pediatr Pathol 8:599Google Scholar
  30. 30.
    Garvin AJ, Gansler T, Gerald W, Sens DA (1991) Insulin-like growth factor production by childhood solid tumors. Perspect Pediatr Pathol 15:106Google Scholar
  31. 31.
    Gerald WL, Stokes Gramlig T, Sens DA (1992) Expression of the 11p13 Wilms' tumor gene, WT1, correlates with histologic category of Wilms' tumor. Am J Pathol 140:1031Google Scholar
  32. 32.
    Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad H (1991) Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138:867Google Scholar
  33. 33.
    Goebel HH (1995) Desmin-related neuromuscular disorders. Muscle Nerve 18:1306Google Scholar
  34. 34.
    Goustin AS, Leof EB, Sjipley GD (1986) Growth factors and cancer. Cancer Res 46:1015Google Scholar
  35. 35.
    Groot-Loonen JJ, Pinkerton CR, Morris-Jones PH (1990) How curable is relapsed Wilms' tumor? Arch Dis Child 65:968Google Scholar
  36. 36.
    Grown AM, Leong AS (1993) Immunohistochemistry of ‘solid’ tumors: poorly differentiated round cell and spindle cell tumors II. In: Leong AS (ed) Applied immunohistochemistry for the surgical pathologist. Edward Arnold, London, p 73Google Scholar
  37. 37.
    Grundy P, Koufos A, Morgan K, Li FP, Meadows AT, Cavenee WK (1988) Familial predisposition to Wilms' tumor does not map to the short arm of chromosome 11. Nature 336:374Google Scholar
  38. 38.
    Hammerman MR (1995) Growth factors in renal development. Semin Nephrol 15:291Google Scholar
  39. 39.
    Hazen-Martin DJ, Garvin AJ, Gansler T, Tarnowski BI, Sens DA (1993) Morphology and growth characteristics of epithelial cells from classic Wilms' tumors. Am J Pathol 142:893Google Scholar
  40. 40.
    Hennigar RA, Beckwith JB (1992) Nephrogenic adenofibroma. A novel kidney tumor of young people. Am J Surg Pathol 16:325Google Scholar
  41. 41.
    Hirschfeld S, Helman L (1994) Diverse roles of insulin-like growth factors in pediatric solid tumors. In Vivo 8:81Google Scholar
  42. 42.
    Hou LT, Holman RL (1996) Bilateral nephroblastomatosis in a premature infant. J Pathol 82:249Google Scholar
  43. 43.
    Huff V, Compton DA, Chao LY, Strong LC, Geiser CF, Saunders GF (1988) Lack of linkage of familial Wilms' tumor to chromosomal band 11p13. Nature 336:377Google Scholar
  44. 44.
    Ishiwata I, Ono I, Ishiwata C, Nakaguchi T, Ohara K, Hirano M, Ishikawa H (1991) Carcinoembryonic proteins produced by Wilms' tumor cells in vitro and in vivo. Exp Pathol 41:1Google Scholar
  45. 45.
    Khine MM, Aung W, Sibbons PD, Howard CV, Clapham E, McGill F, Van Velzen D (1994) Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index. Lab Invest 70:125Google Scholar
  46. 46.
    Lahoti C, Thorner P, Malkin D, Yeger H (1996) Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome. Am J Path 148:1577Google Scholar
  47. 47.
    Leape LL, Breslow NE, Bishop HC (1978) The surgical treatment of Wilms' tumor: results of the National Wilms' Tumor Study. Ann Surg 187:351Google Scholar
  48. 48.
    Lee JM, Bernstein A (1995) Apoptosis, cancer and the p53 tumor suppressor gene. Cancer Metastasis Rev 14:149Google Scholar
  49. 49.
    Leeuwen EH van, Postma A, Oosterhuis JW, Meiring A, Counelisse CJ, Koudstaal J, Molemaar WM (1987) An analysis of histology and DNS-ploidy in primary Wilms' tumors and their metastases and a study of the morphological effects of therapy. Virchows Arch A 410:487Google Scholar
  50. 50.
    Lemerle J, Tournade M, Habrand L (1989) The treatment of Wilms' tumor: An update. In: Murph GP, Khoury S (eds) Therapeutic progress in prological cancers. Alan R Liss, New York, p 629Google Scholar
  51. 51.
    Lemoine NR, Hughes CM, Cowell JK (1992) Aberrant expression of the tumor suppressor gene p53 is very frequent in Wilms' tumors. J Pathol 168:237Google Scholar
  52. 52.
    Loci LM, Cheah PL (1993) An immunohistochemical study comparing clear cell sarcoma of the kidney and Wilms' tumor. Pathology 25:106Google Scholar
  53. 53.
    Mannens M, Slater RM, Heyting C, Bliek J, de Kraker J, Coad N, de Pagter-Holthuizen P, Pearson PL (1988) Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours. Hum Genet 81:41Google Scholar
  54. 54.
    Matsunaga E (1981) Genetics of Wilms' tumor. Hum Genet 57:231Google Scholar
  55. 55.
    Maw MA, Grundy PE, Millow LJ, Eccles MR, Dunn RS, Smith PJ, Feinberg AP, Law DJ, Paterson MC, Telzerow PE (1992) A third Wilms' tumor locus on chromosome 16q. Cancer Res 52:3094Google Scholar
  56. 56.
    Mesfin GM, Breech KT (1996) Heritable nephroblastoma (Wilms' tumor) in the Upjohn Sprague Dawley rat. Lab Animal Sci 46:321Google Scholar
  57. 57.
    Mesrobian HGJ (1988) Wilms tumor: past, present, future. J Urol 140:231Google Scholar
  58. 58.
    Miwa H, Tomlinson GE, Timmons CF, Huff V, Cohn SL, Strong LC, Saunders GF (1992) RNA expression of the WT1 gene in Wilms' tumors in relation to histology. J Natl Cancer Inst 84:181Google Scholar
  59. 59.
    Nagoshi M, Tsuneyoshi M (1994) Expression of proliferating cell nuclear antigen in Wilms' tumors and other pediatric renal tumors: the correlation between histologic classification and proliferative activity. J Surg Oncol 55:114Google Scholar
  60. 60.
    Neely JE, Ballard ET, Britt AF, Workman L (1993) Characteristics of 85 pediatric heterotransplants into nude mice.Expl Cell Biol 51:217Google Scholar
  61. 61.
    Paik S, Rosen N, Jung W, You JM, Lippman ME, Perdue JF, Yee D (1989) Expression of insulin-like growth factor-11 mRNA in fetal kidney and Wilms' tumor. An in situ hybridization study. Lab Invest 61:522Google Scholar
  62. 62.
    Parham DM (1993) Immunohistochemistry of childhood sarcomas: Old and new markers. Mod Pathol 6:133Google Scholar
  63. 63.
    Pritchard-Jones K, Hastie N (1990) Wilms' tumor as a paradigm for the relationship of cancer to development. Cancer Surv 9:555Google Scholar
  64. 64.
    Pritchard-Jones K, Fleming S (1991) Cell types expressing the Wilms' tumor gene (WTI) in Wilms' tumors; implications for tumor histogenesis. Oncogene 6:2211Google Scholar
  65. 65.
    Re GG, Hazen-Martin DJ, Sens DA, Julian Garvin A (1994) Nephroblastoma (Wihns' tumor): A model system of aberrant renal development. Semin Diagn Pathol 11:126Google Scholar
  66. 66.
    Reeve AE, Eccles MR, Wilkins RJ, Bell GI, Millow LJ (1985) Expression of insulin-like growth factor-II transcripts in Wilms' tumor. Nature 317:258Google Scholar
  67. 67.
    Reeve AE, Sih SA, Raizis AM, Feinberg AP (1989) Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells. Mol Cell Biol 9:1799Google Scholar
  68. 68.
    Ren-Qiu Q, Ruelicke T, Hassam S, Haselbacher GK, Schoenle EJ (1993) Systemic effects of insulin-like growth factor-II produced and released from Wilms tumor tissue. Eur J Pediatr 152:102Google Scholar
  69. 69.
    Ren-Qiu Q, Schmitt S, Ruelicke T, Stallmach T, Schoenle EJ (1996) Autocrine regulation of growth by insulin-like growth factor (IGF)-II mediated by type I IGF-receptor in Wilms tumor cells. Pediatr Res 39:160Google Scholar
  70. 70.
    Roald B, Brandtzaeg P (1991) Immunohistochemistry on needle biopsies of childhood malignancies. Pathol Res Pract 187:917Google Scholar
  71. 71.
    Rutna EM, Pekonen F, Makinen T (1988) Soluble 34 K binding proteins inhibit the binding of insulin-like growth factor I to its own receptors in human secretory phase endometrium: Evidence for autocrine/paracrine regulation of growth factor action. J Clin Endocrinol Met 66:173Google Scholar
  72. 72.
    Sarawar SR, Schlingemann RO, Kelsey A, Fleming S, Kumar S (1988) A monoclonal antibody stains blastemal but not tubular components of Wilms' tumor. J Pathol 156:319Google Scholar
  73. 73.
    Scott J, Cowell J, Robertson ME, Priestley LM, Wadey R, Hopkins B, Pritchard J, Bell GI, Rall LB, Graham CF (1985) Insulin-like growth factor-II gene expression in Wilms' tumor and embryonic tissues. Nature 317:260Google Scholar
  74. 74.
    Shimosato Y, Kameya T, Nagia K, Hirohashi S, Koide T, Nomura T, Hayashi H (1976) Transplantation of human tumors in nude mice. J Natl Cancer Inst 56:1251Google Scholar
  75. 75.
    Siles E, Villalobos M, Valenzuela MT, Nunez MI, Gordon A, Mcmillan TJ, Pedraza V, Dealmodovar JMR (1996) Relationship between p53 status and radiosensitivity in human tumor cell lines. Br J Cancer 73:581Google Scholar
  76. 76.
    Slater RM, Mannens MMA (1992) Cytogenetics and molecular genetics of Wilms' tumor of childhood. Cancer Genet Cytogenet 61:111Google Scholar
  77. 77.
    Sola JE, Wojno KJ, Dooley W, Colombani PM (1994) P-glycoprotein status of favorable-histology Wilms' tumor predicts treatment outcome. J Pediatr Surg 29:1080Google Scholar
  78. 78.
    Steenbrugge GJ van, Boijmans AP Ton, Hollander JC den, Jong FH de, Nijman JM Rien (1995) Human Wilms' tumor models in nude mice: properties, in vitro growth and expression of activtn receptors. Urol Res 23:262Google Scholar
  79. 79.
    Stone CH, Lynch EF, Linden MD, Kubus JJ, Zarbo RJ (1996) Immunocytochemical evaluation of proliferating cell nuclear antigen, ki-67 (MIB-1), and p53 in predicting survival of primary and metastatic malignant melanomas. Appl Immunohistochem 4:25Google Scholar
  80. 80.
    Sumino K, Nagashima Y, Ohaki Y, Umeda M (1992) Isolation of subclones with different tumorigenicity and metastatic ability from rat nephroblastoma cell line, ENUT. Acta Pathologica Japonica 42:166Google Scholar
  81. 81.
    Takeuchi S, Bartram CR, Ludwig R, Royer-Pokora B, Schneider S, Imamura J, Koefller HP (1995) Mutations of p53 in Wihns' tumors. Mod Pathol 8:483Google Scholar
  82. 82.
    Talts JF, Aufderheide E, Sorokin L, Ocklind G, Mattsson R, Ekblom P (1993) Induction of mouse tenascin expression by a human sarcomatoid Wilms' tumor cell line growing in nude mice. Int J Cancer 54:868Google Scholar
  83. 83.
    Tarnowski BI, Hazin-Martin DJ, Garvin AJ, Sens MA (1994) Characterization of a monoclonal antibody recognizing the blastemal element of Wilms' tumors and fetal kidneys. Pediatr Pathol 14:849Google Scholar
  84. 84.
    Tessarollo L, Tsoulfas P, Martin-Zanca D, Gilbert D, Jenkins N, Copeland N, Parada L (1993) Trk C, a receptor for meurotrophin-3, is widely expressed in the developing nervous system and in non-neuronal tissues. Development 118:463Google Scholar
  85. 85.
    Thomson TM, Pellicer A, Greene LA (1989) Functional receptors for nerve growth factor on Ewing's sarcoma and Wilm's tumor cells. J Cell Physiol 141:60Google Scholar
  86. 86.
    Tomomura M, Kadomatsu K, Matsubara S, Muramatsu T (1990) A retinoic acid-responsive gene, MK, found in the teratocarcinoma system. Heterogeneity of the transcript and the nature of the translation-product. J Biol Chem 265:10765Google Scholar
  87. 87.
    Tsutsui J, Kadomatsu K, Matsubara S, Nakagawara A, Hamanoue M, Takao S, Shimazu H, Ohi Y, Muramatsu T (1993) A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res 53:1281Google Scholar
  88. 88.
    Waber PG, Jun Chen MLS, Nisen PD (1993) Infrequency of ras, p53, WT1, of RB gene alterations in Wilms tumors. Cancer 72:3732Google Scholar
  89. 89.
    Weerden WM van, Ridder CMA de, Verdaasdonk CL, Romijn JC, Kwast TH van der, Schröder FI, Steenbrugge GJ van (1996) Seven newly developed human prostate tumor xenograft models: establishment and histopathological characterization. Am J Pathol 149:1055Google Scholar
  90. 90.
    Weissman BE, Saxon PJ, Pasquale SR, Jones GR, Geiser AG, Stanbridge EJ (1987) Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression. Science 236:175Google Scholar
  91. 91.
    Wiliams JA, Douglass EC, Hammond E (1985) Relapsed Wilms' tumor, factors affecting survival and cure.Am J Clin Oncol (CCT) 8:324Google Scholar
  92. 92.
    Wilms M (1889) Die Mischgeschwuelste der Niere. Arthur Georgi, Leipzig, p 1Google Scholar
  93. 93.
    Yeger H, Baumal R, Pawlin G, Phillips MJ (1985) Relationship of histology of Wilms' tumor to growth characteristics of nude mouse heterotransplants. Cancer Res 45:2340Google Scholar
  94. 94.
    Yoshiyuki T, Shimizu Y, Onda M, Tokunaga A, Kiyama T, Nishi K, Mizutani T, Matsukura N, Tanaka N, Akimoto M, Asano G (1989) Immunohistochemical demonstration of epidermal growth factor in human gastric cancer xenograft of nude mice. Cancer 65:953Google Scholar

Copyright information

© Springer-Verlag 1997

Authors and Affiliations

  • J. G. Wen
    • 1
  • G. J. van Steenbrugge
    • 1
  • R. M. Egeler
    • 2
  • R. M. Nijman
    • 3
  1. 1.Division of Urological Oncology, Medical FacultyErasmus University RotterdamRotterdamThe Netherlands
  2. 2.Department of Pediatric OncologySophia Children's HospitalRotterdamThe Netherlands
  3. 3.Department of Pediatric UrologyInstitute of Urology, Erasmus University and Sophia Children's Hospital RotterdamThe Netherlands

Personalised recommendations